675 related articles for article (PubMed ID: 10682513)
1. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B; Jia L; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
[TBL] [Abstract][Full Text] [Related]
2. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses.
Sohn YM; Tandan JB; Yoksan S; Ji M; Ohrr H
Vaccine; 2008 Mar; 26(13):1638-43. PubMed ID: 18294743
[TBL] [Abstract][Full Text] [Related]
3. Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand.
Chotpitayasunondh T; Sohn YM; Yoksan S; Min J; Ohrr H
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S195-203. PubMed ID: 22043776
[TBL] [Abstract][Full Text] [Related]
4. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
Janewongwirot P; Puthanakit T; Anugulruengkitt S; Jantarabenjakul W; Phasomsap C; Chumket S; Yoksan S; Pancharoen C
Vaccine; 2016 Oct; 34(44):5279-5283. PubMed ID: 27628323
[TBL] [Abstract][Full Text] [Related]
6. Protection of SA14-14-2 live attenuated Japanese encephalitis vaccine against the wild-type JE viruses.
Jia L; Wang Z; Yu Y
Chin Med J (Engl); 2003 Jun; 116(6):941-3. PubMed ID: 12877812
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiological characteristics and related influencing factors on Japanese encephalitis in Hainan Province].
Pan XH; Sun LY; Wang CL; Zhu J; Fu ZW; Zeng ZC; Zeng XX; Yan XJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 May; 30(5):471-4. PubMed ID: 19799143
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
Yang SE; Pan MJ; Tseng HF; Liau MY
Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China.
Ding D; Kilgore PE; Clemens JD; Wei L; Zhi-Yi X
Bull World Health Organ; 2003; 81(5):334-42. PubMed ID: 12856051
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological situation of Japanese encephalitis in Nepal.
Bista MB; Shrestha JM
JNMA J Nepal Med Assoc; 2005; 44(158):51-6. PubMed ID: 16554872
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study.
Luo D; Yin H; Xili L; Song J; Wang Z
Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):643-6. PubMed ID: 7667706
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology study of Japanese encephalitis neutralizing antibodies in southern Taiwan: a comparative study between urban city and country townships.
Tseng HF; Tan HF; Chang CK; Huang WL; Ho WC
Am J Infect Control; 2003 Nov; 31(7):435-40. PubMed ID: 14639442
[TBL] [Abstract][Full Text] [Related]
13. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
[TBL] [Abstract][Full Text] [Related]
14. A community-based study of subclinical flavivirus infections in children in an area of Tamil Nadu, India, where Japanese encephalitis is endemic.
Gajanana A; Thenmozhi V; Samuel PP; Reuben R
Bull World Health Organ; 1995; 73(2):237-44. PubMed ID: 7743596
[TBL] [Abstract][Full Text] [Related]
15. A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.
Kim DS; Houillon G; Jang GC; Cha SH; Choi SH; Lee J; Kim HM; Kim JH; Kang JH; Kim JH; Kim KH; Kim HS; Bang J; Naimi Z; Bosch-Castells V; Boaz M; Bouckenooghe A
Hum Vaccin Immunother; 2014; 10(9):2656-63. PubMed ID: 25483480
[TBL] [Abstract][Full Text] [Related]
16. Cost benefit analysis of Japanese encephalitis vaccination program in Thailand.
Siraprapasiri T; Sawaddiwudhipong W; Rojanasuphot S
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):143-8. PubMed ID: 9322297
[TBL] [Abstract][Full Text] [Related]
17. Japanese encephalitis: surveillance and elimination effort in Japan from 1982 to 2004.
Arai S; Matsunaga Y; Takasaki T; Tanaka-Taya K; Taniguchi K; Okabe N; Kurane I;
Jpn J Infect Dis; 2008 Sep; 61(5):333-8. PubMed ID: 18806337
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
[TBL] [Abstract][Full Text] [Related]
19. [Seroepidemiology of Japanese encephalitis viral infection among 3-6 years old children from mountainous and plains townships located in the northern, central, southern and eastern Taiwan].
Hsu LC; Wu YC; Lin SR; King CC; Ho MS; Lu CF; Hsu HM; Chen KT; Horng CB
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Aug; 30(3):194-206. PubMed ID: 10592824
[TBL] [Abstract][Full Text] [Related]
20. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China.
Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC
Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
